ANVS - Annovis to release efficacy data on Alzheimer's drug in April
2024-03-20 09:50:03 ET
More on Annovis Bio
- Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects
- Annovis And Alzheimer's Disease: The Best-Laid Plans
- Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO
- Annovis Bio falls after Brookline Capital downgrades on PD trial complications
- Annovis falls 16% on Phase 3 data delay for Parkinson's drug